FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> development pact   India   Ranbaxy   Merck
Syndicate content

Malvinder Mohan Singh News

Most Popular Malvinder Mohan Singh Story

Merck turns to Ranbaxy for $100M R&D effort

India's Ranbaxy has flexed its research muscles once again, this time signing a five-year pact with Merck to develop new anti-infectives. Ranbaxy, which received an undisclosed upfront payment, says... Read more...

Latest Headlines